InterCure to Acquire ISHI in Two-Phase Deal
Ticker: INCR · Form: 6-K · Filed: Sep 19, 2025 · CIK: 1857030
| Field | Detail |
|---|---|
| Company | Intercure Ltd. (INCR) |
| Form Type | 6-K |
| Filed Date | Sep 19, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, cannabis, agreement
TL;DR
InterCure is buying ISHI in a phased deal, aiming to boost its cannabis tech and brand portfolio.
AI Summary
On September 17, 2025, InterCure Ltd. entered into a share purchase agreement to acquire 100% of ISHI (Botanico Ltd.), an Israeli cannabis company, in a two-phase transaction. The agreement outlines the acquisition of 50% of ISHI's issued and outstanding shares in the first phase.
Why It Matters
This acquisition could expand InterCure's market presence and access to premium cannabis products and technologies, potentially impacting its competitive position in the industry.
Risk Assessment
Risk Level: medium — The acquisition involves a phased approach and details of the second phase are not fully disclosed, introducing some uncertainty.
Key Numbers
- 100% — ISHI Acquisition (InterCure aims to acquire full ownership of ISHI.)
- 50% — Initial Share Purchase (The first phase of the acquisition involves purchasing 50% of ISHI's shares.)
Key Players & Entities
- InterCure Ltd. (company) — Acquiring company
- Botanico Ltd. (company) — Target company, also known as ISHI
- ISHI (company) — Target company, also known as Botanico Ltd.
- September 17, 2025 (date) — Date of share purchase agreement
FAQ
What is the total value of the share purchase agreement for ISHI?
The filing does not disclose the total dollar amount of the share purchase agreement.
When was the share purchase agreement signed?
The share purchase agreement was entered into on September 17, 2025.
What is the name of the company InterCure Ltd. is acquiring?
InterCure Ltd. is acquiring Botanico Ltd., also known as ISHI.
How many phases will the acquisition of ISHI be completed in?
The acquisition of ISHI will be completed in two phases.
What percentage of ISHI will InterCure acquire in the first phase?
InterCure will acquire 50% of ISHI's issued and outstanding shares in the first phase.
Filing Stats: 957 words · 4 min read · ~3 pages · Grade level 15.3 · Accepted 2025-09-19 08:49:01
Filing Documents
- form6-k.htm (6-K) — 24KB
- ex99-1.htm (EX-99.1) — 25KB
- ex99-2.htm (EX-99.2) — 544KB
- ex99-1_001.jpg (GRAPHIC) — 17KB
- 0001493152-25-014152.txt ( ) — 617KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. INTERCURE LTD. Date: September 19, 2025 /s/ Amos Cohen Amos Cohen Chief Financial Officer